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Abstract
Reactive oxygen species (ROS) have been implicated in the pathogenesis of acute pancreatitis (AP) for many years but
experimental evidence is still limited. Uncoupling protein 2 (UCP2)-deficient mice are an accepted model of age-related
oxidative stress. Here, we have analysed how UCP2 deficiency affects the severity of experimental AP in young and older
mice (3 and 12 months old, respectively) triggered by up to 7 injections of the secretagogue cerulein (50 mg/kg body
weight) at hourly intervals. Disease severity was assessed at time points from 3 hours to 7 days based on pancreatic
histopathology, serum levels of alpha-amylase, intrapancreatic trypsin activation and levels of myeloperoxidase (MPO) in
lung and pancreatic tissue. Furthermore, in vitro studies with pancreatic acini were performed. At an age of 3 months,
UCP2-/- mice and wild-type (WT) C57BL/6 mice were virtually indistinguishable with respect to disease severity. In contrast,
12 months old UCP2-/- mice developed a more severe pancreatic damage than WT mice at late time points after the
induction of AP (24 h and 7 days, respectively), suggesting retarded regeneration. Furthermore, a higher peak level of alpha-
amylase activity and gradually increased MPO levels in pancreatic and lung tissue were observed in UCP2-/- mice.
Interestingly, intrapancreatic trypsin activities (in vivo studies) and intraacinar trypsin and elastase activation in response to
cerulein treatment (in vitro studies) were not enhanced but even diminished in the knockout strain. Finally, UCP2-/- mice
displayed a diminished ratio of reduced and oxidized glutathione in serum but no increased ROS levels in pancreatic acini.
Together, our data indicate an aggravating effect of UCP2 deficiency on the severity of experimental AP in older but not in
young mice. We suggest that increased severity of AP in 12 months old UCP2-/- is caused by an imbalanced inflammatory
response but is unrelated to acinar cell functions.
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Introduction
With an annual incidence of 13–45 cases per 100.000 persons,
acute pancreatitis (AP) is among the leading causes of hospitaliza-
tion for gastrointestinal disorders worldwide [1]. Given that
mortality ranges from 3% for patients with edematous AP [2] to
up to 30% in severe cases [1], treatment of the disease remains a
clinical challenge. For decades, AP has been considered only as an
autodigestive disease caused by intrapancreatic activation of
digestive proteases, and indeed it is well established that premature
trypsinogen activation leads to acinar cell death by enzymatic
necrosis, which represents an important component of acinar
injury in AP (reviewed in [3]). More recent studies have added
activation of intense inflammatory signaling mechanisms in acinar
cells to the key mechanisms of AP pathogenesis. Furthermore,
observations about the occurrence of local and systemic inflam-
mation in AP, independently of premature trypsinogen activation,
have challenged solely trypsin-centered theories of the disease [3].
Reactive oxygen species (ROS) have been implicated in
pancreatitis many years ago [4,5], but still the precise role of
ROS in the pathogenesis of the disease remains controversial. On
one hand, increased ROS levels have been observed early in the
course of AP, and preclinical studies have often suggested
beneficial effects of antioxidant treatments [6–8]. Clinical studies
with antioxidants, on the other hand, have yielded conflicting and
frequently disappointing results [9–11]. Moreover, recent studies
have put the simple concept of a general detrimental action of
ROS into question by showing that increases of intracellular and
mitochondrial ROS concentrations during bile acid injury of
pancreatic acinar cells selectively promote apoptosis as a
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predominantly protective form of cell death in the context of AP
[12].
Uncoupling protein 2 (UCP2) is a mitochondrial inner
membrane carrier protein [13] that is expressed in many tissues,
including pancreas [14–16] and specifically pancreatic acinar cells
[16]. Accumulating evidence suggests that UCP2 functions as a
negative regulator of mitochondria-derived ROS production by
decreasing the mitochondrial membrane potential [17–19]. Thus,
experimental overexpression of UCP2 provides cytoprotection by
limiting ROS formation [20,21], while defects of UCP2 expression
or an inhibition of UCP2 function display the opposite effect
[22,23]. Interestingly, an increase of UCP2 expression in ageing
tissues (liver and skeletal muscle) has been observed and may be
important to attenuate ageing-associated oxidative stress burden,
as also suggested by studies in UCP2-/- mice [24,25].
Deletion of UCP2 has been shown to severely affect immune
responses, first of all but not exclusively by favoring macrophage
activity (through increased ROS production and enhancement of
ROS signaling; reviewed in [26]). Furthermore, an ucp2 promoter
polymorphism has been linked to chronic inflammatory diseases
such as rheumatoid arthritis and systemic lupus erythematosus
[27].
In two models of experimental AP, pancreatic UCP2 mRNA
levels were found to be increased and correlated with the severity
of the disease [16]. The authors proposed that up-regulation of
UCP2 in the pancreas may be a protective response to oxidative
stress, but also discussed a potential negative effect of UCP2 on
cellular energy metabolism. Furthermore, they suggested acinar
UCP2 as an important modifier of the severity of AP.
Here, we took advantage of the UCP2-/- mouse model to study
the role of ROS in the pathogenesis of experimental acute AP in a
well-defined genetic context, and to directly assess specific
functions of UCP2. Therefore, two age groups of mice, young
adults (3 months old) and older animals (12 months old), were
employed. Our data indicate that 12 months old UCP2-/- mice but
not the younger individuals are prone to develop a more severe
disease than wild-type (WT) controls. Furthermore, the results
provide insights into underlying cellular and molecular mecha-
nisms.
Materials and Methods
Reagents
Unless stated otherwise, all reagents were obtained from Sigma-
Aldrich (Deisenhofen, Germany).
Animal Studies
UCP2-/- mice [28] were purchased from Charles River
Laboratories (Sulzfeld, Germany) and kept on the C57BL/6
background (WT control strain). All experiments were performed
according to the guidelines of the local animal use and care
committee, which also approved this study (Landesamt fu¨r
Landwirtschaft, Lebensmittelsicherheit und Fischerei Mecklen-
burg-Vorpommern, permit number for the study: LALLF M-V/
TSD/7221.3-1.1-077/11). The mice had access to water and
standard laboratory chow ad libitum. All animals received humane
care according to the German legislation on protection of animals
and the Guide for the Care and Use of Laboratory Animals (NIH
publication 86–23, revised 1985), and all efforts were made to
minimize suffering.
The studies were performed with balanced numbers of female
and male mice at an age of 3 or 12 months as indicated. Prior to
the experiments, the mice were fasted overnight with free access to
water. Afterwards, the secretagogue cerulein (Bachem, Heidelberg,
Germany) was administered in seven intraperitoneal injections of
50 mg/kg body weight at hourly intervals [29,30]. Mice were
euthanized by an overdose of ketamine/xylazin hydrochloride at
intervals between 3 hours and 7 days after the first intraperitoneal
injection of cerulein. Lung tissue, pancreas and serum (obtained
from whole blood) were harvested and stored under appropriate
conditions (280uC for shock-frozen native tissue) until they were
assayed.
Amylase Measurement
Alpha-amylase (a-amylase) activity in serum was determined in
a routine laboratory using the IFCC reference method [31] (AMY
reagent; Beckman Coulter, Mervue, Galway, Ireland).
For the detection of pancreatic a-amylase, $30 mg of
pancreatic tissue was homogenized in phosphate-buffered saline
(PBS; pH 7.0, 20 mmol/L) using an Ultra-Turrax T10 disperser
(IKA works, Staufen, Germany) and subjected to sonication. All
steps were performed on ice and with pre-cooled reagents and
instruments. After clearing the lysates by centrifugation, the
supernatants were stored at 280uC until assayed. Measurements
of a-amylase activity were performed as described above.
Histology, Immunohistochemistry and Detection of
Apoptotic Cells in situ
For histology, pancreata were fixed in 4% formaldehyde
phosphate buffer overnight and processed for paraffin embedding.
Routine hematoxylin and eosin (H&E) staining for determination
of organ inflammation was performed on 1 mm sections using
standard procedures. Histopathological evaluation of pancreatic
injury was performed by light microscopy. Severity of organ
inflammation was determined on blinded samples, employing a
semiquantitative score to assess the following four key parameters
of cerulein-induced AP [29,30]: (1) the degree of edema, (2) the
presence of potentially reversible cellular damage (cell swelling,
vacuolization and cystic degeneration), (3) the frequency of dead
(apoptotic or necrotic) cells, and (4) the number of infiltrating
inflammatory cells. Each parameter was evaluated on a scale from
Figure 1. Analysis of redox status in serum of WT and UCP2-/-
mice. Serum samples of 3 and 12 months old UCP2-/- and WT C57BL/6
mice (n = 7–8) were used to measure total GSH and GSSG levels. Data
are given as GSH/GSSG ratio (mean 6 SEM).
doi:10.1371/journal.pone.0094494.g001
Acute Pancreatitis in UCP2-Deficient Mice
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0–3 (0 being normal and 3 being severe) and the sum was
calculated, resulting in a maximum total score of 12.
Infiltrating inflammatory cells were further classified by
immunohistochemical analysis, applying an avidin–biotin-peroxi-
dase (ABC) technique and reagents that were delivered (unless
indicated otherwise) by Vector Laboratories (Burlingame, CA,
USA). Therefore, air-dried cryostat sections (6 mm) were fixed by
incubation in ice-cold methanol for 30 s. After three washing steps
with PBS, sections were treated, in two subsequent steps of
15 min, with Avidin D and biotin solution (Avidin/Biotin blocking
kit) to block endogenous biotin and biotin-binding proteins. Next,
slides were incubated for 60 min with PBS containing 2.0% goat
serum, followed by exposure to rat anti-mouse antibodies against
CD11b (ImmunoTools, Friesoythe, Germany), Gr1 (eBioscience,
Frankfurt, Germany) and CD3 (BD Pharmingen, Heidelberg,
Germany) diluted in 2.0% goat serum/PBS for 90 min. Subse-
quently, sections were washed and exposed to biotinylated goat
anti-rat immunoglobulin (diluted in 2.0% goat serum/PBS) for
30 min. After further washing steps, the sections were incubated
with ABC reagent for 30 min, before target proteins were
visualized using the peroxidase substrate and chromogen No-
vaRED. Slides were counterstained with Mayer’s hemalum
solution, dehydrated by four short incubations in ethanol and
xylene (two times each) and embedded in Pertex (MEDITE,
Burgdorf, Germany).
Apoptotic cells in pancreatic tissue were detected employing the
ApopTag Peroxidase Apoptosis Detection Kit according to the instruc-
tions of the manufacturer (Millipore, Billerica, MA, USA). The kit
is based on the TUNEL method and stains apoptotic cells in situ by
labeling DNA strand breaks. Briefly, cryostat sections (6 mm) were
fixed by incubation in paraformaldehyde (1%) for 10 min at room
temperature (RT). Next, the tissue was permeabilized by
incubation in ethanol/acetic acid (2:1 mixture) for 5 min at 2
20uC before endogenous peroxidase activity was blocked with
hydrogen peroxide solution (3%; 5 min at RT). After short
incubation with Equilibration Buffer, Terminal Deoxynucleotidyl Trans-
Figure 2. Measurements of a-amylase activities in WT and UCP2-/- mice. (A) Mice of two age groups (3 and 12 months, respectively) were
sacrificed at the indicated time points after the start of cerulein treatment (n = 6–8 mice per experimental time point) and serum samples subjected to
the analysis of a-amylase activities. Data are expressed as units per milliliter of serum (mean values 6 SEM). *P,0.05 (12 months old WT versus
UCP2-/- mice). (B) Pancreatic tissue of untreated WT and UCP2-/- mice at an age of 12 months (n = 6 per group) was subjected to the detection of a-
amylase activities. Data are expressed as U/mg wet weight (mean 6 SEM).
doi:10.1371/journal.pone.0094494.g002
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Figure 3. Histopathology of pancreatic lesions in cerulein-treated 12 months old WT C57BL/6 mice. Pancreatic sections were stained
with H&E. Photographs A–E display representative examples of pancreatic damage at the time points 0 h, 3 h, 8 h, 24 h and 7 days after the start of
cerulein treatment. (A) 0 h – healthy pancreas (B) 3 h – focal cell swelling, vacuolization and cystic degeneration, death of single cells (C) 8 h – in
addition to the changes at 3 h progressive interstitial edema and widespread cell death (D) 24 h – interstitial edema, cell degeneration and multiple
apoptotic and necrotic cells; presence of interstitial inflammatory cells (E) day 7 – slight residual cell swelling. Photograph (F) from a mouse on day 7
shows an additional incidental finding occasionally observed especially in 12 months old mice: lymphoplasmacytic and eosinophilic interstitial
infiltrate surrounding ducts and vessels; compatible with an autoimmune pancreatitis.
doi:10.1371/journal.pone.0094494.g003
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Figure 4. Histopathology of pancreatic lesions in cerulein-treated 12 months old UCP2-/- mice. Pancreatic sections were stained with
H&E. Photographs A–E display representative examples of pancreatic damage at the time points 0 h, 3 h, 8 h, 24 h and 7 days after the start of
cerulein treatment. In addition to the findings described in Fig. 3, more pronounced histopathological changes at the time points 24 h (D – edema
and presence of interstitial inflammatory cells) and day 7 (E – edema and cell damage) were observed.
doi:10.1371/journal.pone.0094494.g004
Acute Pancreatitis in UCP2-Deficient Mice
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ferase Enzyme solution was applied to the tissue (60 min at 37uC),
before the labeling reaction was stopped with Stop/Wash Buffer.
Subsequently, Anti-Digoxigenin Peroxidase Conjugate was added
(30 min at RT). Finally, tissue sections were incubated with the
peroxidase substrate 3,39 diaminobenzidine for 5 min, counter-
stained with methyl green at 0.5% (10 min), dehydrated with
xylene and embedded in Pertex.
Positive-stained cells (ABC staining ApopTag Kit, respectively) were
counted in ten representative areas per section (one area
= 0.09 mm2).
Detection of Trypsin Activity in vivo
Pancreata were homogenized in MOPS buffer (5 mmol/L
MOPS pH 6.5, 1 mmol/L MgSO4, 250 mmol/L Saccharose) and
trypsin activity was determined fluorometrically following pub-
lished protocols [32]. All steps were performed on ice and with
pre-cooled reagents. To determine the content of active trypsin in
the homogenate, the synthetic substrate BOC-Gln-Ala-Arg-7-
amido-4-methylcoumarin HCl (Peptanova, Sandhausen, Ger-
many) was applied at a final concentration of 30 mmol/L in Tris
buffer (50 mmol/L Tris pH 8.0, 150 mmol/L NaCl, 1 mmol/L
CaCl2, 0.01% BSA). Fluorescence of the cleavage product 7-
amino-4-methylcoumarin (AMC) was recorded using an Infinite
200 microplate reader (Tecan Group Ltd., Ma¨nnedorf, Switzerland)
and an excitation/emission wavelength of 360/438 nm, respec-
tively (reaction temperature: 30uC, 20 cycles of 30 s measure-
ment). Protein concentrations of the homogenates were quantified
according to Bradford [33]. Trypsin concentration was calculated
using bovine trypsin as a standard.
Measurement of Myeloperoxidase (MPO) Activity
MPO activities in pancreatic and lung tissue were determined
using the MPO fluorometric detection kit from Enzo Life Sciences
(Lo¨rrach, Germany). The kit uses a non-fluorescent detection
reagent, which is oxidized in the presence of hydrogen peroxide
and MPO to produce its fluorescent analog. All steps were
Figure 5. Semiquantitative evaluation of pancreatic lesions in cerulein-treated WT and UCP2-/- mice. Three and 12 months old UCP2-/-
and WT C57BL/6 mice were treated with cerulein as indicated (n = 6–8 per time point, strain and age group). Pancreatic sections of the mice were
stained with H&E and scored as described in the ‘‘Materials and methods’’ section. The total histological score shown in (A) represents the sum of the
scores for edema (B), potentially reversible cell damage (C), cell death (D) and infiltration with immune cells (E), each of which scored on a scale from
0–3. Data are shown as mean 6 SEM. *P,0.05 (WT versus corresponding UCP2-/- mice).
doi:10.1371/journal.pone.0094494.g005
Figure 6. Immunohistochemical analysis of leucocyte infiltrates and quantification of apoptotic cells in cerulein-treated WT and
UCP2-/- mice. Pancreatic sections of 12 months old mice at the indicated time points after initiation of cerulein treatment (n = 8 per group) were
processed applying the ABC technique and antibodies to CD11b (A), Gr1 (B) and CD3 (C), or stained with the ApopTag Kit for the detection of
apoptotic cells (D). Positive-stained cells were counted, and mean values 6 SEM were calculated. *P,0.05 (WT versus corresponding UCP2-/- mice).
doi:10.1371/journal.pone.0094494.g006
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performed on ice and with pre-cooled reagents. Approximately
100 mg of lung and $30 mg of pancreatic tissue was homoge-
nized in assay buffer supplemented with N-Ethylmaleimide
(10 mmol/L). Samples of lung tissue were adjusted to concentra-
tions of 25 mg tissue/mL and samples of pancreatic tissue to
concentrations of 11 mg/mL assay buffer. After a centrifugation at
10.0006g for 20 min at 4uC, the pellet was dissolved in 1 mL of
solubilization buffer, sonicated and subjected to two cycles of freeze/
thaw. Following another step of centrifugation (8.0006g, 20 min
at 4uC), the supernatant was stored at 280uC until assayed.
MPO activity was measured in 96-well black plates, using 50 mL
of sample and 50 mL of reaction cocktail. After 60 min of incubation
in the dark, fluorescence was recorded using an Infinite 200
microplate reader and an excitation/emission wavelength of 550/
595 nm, respectively. MPO activity was calculated using a MPO
standard delivered with the kit.
Redox Status in Serum of UCP2-/- and C57BL/6 Mice
To analyze redox status in serum of UCP2-/- and C57BL/6
mice, the ratio of glutathione (GSH) to glutathione disulfide
(GSSG) was determined using the EnzyChrom GSH/GSSG Assay
according to the manufacturer’s instructions (BioAssay Systems,
CA, USA). Therefore, each serum sample was divided into two
parts. One half was used to measure GSSH, the other to
determine total glutathione. In case of GSSG detection, samples
were preincubated with 1-methyl-2-vinylpyridinium triflate for
10 min at RT. Afterwards, all samples were deproteinated
employing 5% metaphosphoric acid and cleared by centrifugation.
The supernatants were mixed with assay buffer, incubated with
working reagent (containing gluthatione reductase and Ellman’s
reagent), and optical density at 412 nm was determined using an
Infinite 200 microplate reader. Results are expressed as a ratio of
GSH/GSSG.
In vitro Studies with Pancreatic Acini
Acini were freshly prepared from the mouse pancreas by
digestion with collagenase [34,35]; suspended in HEPES
(24.5 mmol/L)-buffered medium (pH 7.5) containing NaCl
(96 mmol/L), KCl (6 mmol/L), MgCl2 (1 mmol/L), NaH2PO4
(2.5 mmol/L), CaCl2 (0.5 mmol/L), glucose (11.5 mmol/L), Na-
pyruvate (5 mmol/L), Na-glutamate (5 mmol/L), Na-fumarate
(5 mmol/L), minimum essential medium (1% v/v), and bovine
serum albumin, fraction V (1% w/v). Immediately after isolation,
more than 99.9% of the acinar cells were found to be viable by
trypan blue staining. The rate of cell death slightly increased in the
course of incubation but still remained below 5% at the latest
experimental time point (90 min, see below).
For the detection of protease activities, acini were adjusted to a
biovolume concentration of 2 mm3/mL living cells. After an
equilibration period of 30 min, cerulein (Bachem) was added at
the supramaximal concentration of 10 nmol/L for up to 90 min at
a temperature of 37uC. Subsequently, acini were washed and
resuspended in medium without secretagogue but in the presence
of synthetic substrates for trypsin (CBZ-Ile-Pro-Arg)2-rhodamine-
110 (10 mmol/L) and elastase (CBZ-Ala4)2-rhodamine-110
(10 mmol/L) (Fisher Scientific, Schwerte, Germany), respectively.
To quantify substrate cleavage, cerulein-treated acini and control
cultures, together with the substrate, were transferred to 96-well
microtiter plates. The change of fluorescence intensity (DF) over a
time period of 90 min was determined at RT by cytofluorometry
at 485 nm excitation and 530 nm emission wavelengths (Cyto-
Fluor 2350; Millipore, Bedford, MA) and expressed as DF/Dt ratio
as previously reported [36].
To measure intraacinar levels of trypsinogen and proelastase,
both proenzymes were activated in vitro by incubation with active
trypsin (which was chosen since enterokinase would cleave the
elastase substrate). Therefore, adjusted biovolumes of acinar cells
(1.2–1.3 mm3/mL) were washed and resuspended in acetate
buffer (50 mmol/L, pH 5.0) supplemented with NaCl
(100 mmol/L), ethylenediaminetetraacetic acid (4 mmol/L) and
dithiothreitol (8 mmol/L). After cell lysis by sonication, the lysates
were cleared by centrifugation and the supernatants incubated
with trypsin (1 nmol/L; porcine protein; SERVA, Heidelberg,
Germany) for 30 min at 37uC. Afterwards, measurements of
trypsin and elastase activities were performed as described above,
except of that the time period was reduced to 60 min.
Subsequently, DF/Dt ratios were calculated and corrected by
subtracting the corresponding values obtained from control
samples where the cell lysate was replaced by assay buffer
supplemented with trypsin at 1 nmol/L.
For the detection of intracellular ROS levels, 29,79-dichloro-
fluorescin diacetate (DCFH-DA) was employed. DCFH-DA, a
cell-permeable non-fluorescent probe, is de-esterified intracellu-
larly and turns to highly fluorescent 29,79-dichlorofluorescein upon
oxidation in the presence of hydroxyl, peroxyl and other ROS
activity. Therefore, acini were adjusted to a biovolume concen-
tration of 1 mm3/mL, transferred to black 96-well plates and
preincubated with DCFH-DA (dissolved in dimethyl sulfoxide) at a
final concentration of 50 mmol/L for 30 min at RT. Afterwards,
the cells were spun down by centrifugation, resuspended in
DCFH-DA-free assay medium (HEPES 24.5 mmol/L; pH 7.4,
NaCl 96 mmol/L, KCl 6 mmol/L, MgCl2 1 mmol/L, NaH2PO4
2.5 mmol/L, glucose 11.5 mmol/L, CaCl2 0.5 mmol/L, Na-
pyruvate 5 mmol/L, Na-glutamate 5 mmol/L, Na-fumarate
5 mmol/L, Eagle medium 10% v/v, bovine serum albumin
fraction V 1% w/v) and exposed to cerulein at either supramax-
imal (10 nmol/L) or maximal (0.1 nmol/L) concentrations for
30 min as indicated. Finally, fluorescence intensity was determined
at 495 nm excitation and 529 nm emission wavelengths using an
automated fluorescence reader (GloMax-Multi+ Detection Sys-
tem, Promega, Madison, WI, USA). Data are expressed as
percentage of controls as described in the figure legend.
Figure 7. Determination of trypsin activity in pancreatic tissue
of cerulein-treated WT and UCP2-/- mice. Tissue samples of 12
months old mice at the indicated time points after initiation of cerulein
treatment (n = 7–8 per group) were subjected to the quantification of
trypsin activity as described in the ‘‘Materials and methods’’ section.
Data are expressed as fmol active trypsin per mg pancreatic protein
(mean 6 SEM). *P,0.05 (WT versus corresponding UCP2-/- mice).
doi:10.1371/journal.pone.0094494.g007
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Statistical Analysis
Results are expressed as mean 6 standard error of the mean
(SEM) for the indicated number of animals/samples per exper-
imental protocol. Statistical significance was checked using the
Mann-Whitney U test. P,0.05 was considered to be statistically
significant.
Results
Effects of UCP2 Gene Knockout on the Redox Status
In this study, the ratio of reduced and oxidized glutathione
(GSH/GSSG) in serum was determined as a surrogate marker of
the redox status. Both at an age of 3 and 12 months, UCP2-/- mice
displayed the lower ratio, suggesting increased oxidative stress
(inverse relationship), although the difference did not reach
statistical significance (Fig. 1). In both strains, the GSH/GSSG
ratios at 3 and 12 months showed little variation.
Severity of Pancreatitis in WT and UCP2-/- Mice
To study the effects of a UCP2 gene knockout on the course of
acute experimental pancreatitis, we employed the standard model
of 7 repeated cerulein injections at hourly intervals [29,30]. Again,
two age groups, 3 and 12 months old mice, were included in order
to determine age-dependent effects of UCP2-deficiency. As shown
in Fig. 2 A, mice of both strains and age groups displayed a strong
increase of a-amylase levels in serum with a peak after 8 hours and
a return to baseline levels until day 7. While a-amylase activities in
3 months old mice of both strains and in 12 months old UCP2-/-
mice were very similar at any time point, WT mice at an age of 12
months reached a significantly lower maximum serum enzyme
level. Since basal a-amylase activities in pancreatic tissue were the
same in 12 months old mice of both strains (Fig. 2 B), the observed
difference in maximum serum amylase activity cannot be
attributed to a strain-dependent pancreatic content of the enzyme.
To further assess pancreatic damage, histological evaluations
were performed. In Fig. 3 (A–E), typical pathomorphological
changes in the course of acute cerulein-induced pancreatitis are
shown for the example of 12 months old WT mice. The
Figure 8. Trypsin and elastase activities in pancreatic acini isolated fromWT and UCP2-/- mice. Isolated pancreatic acini of 12 months old
WT and UCP2-/- mice were treated in vitro with cerulein (10 nmol/L) for up to 90 min. Subsequently, cleavage of rhodamine 110-labeled synthetic
substrates for (A) trypsin and (B) elastase was recorded by cytofluorometry. To compare proteolytic activities, DF/Dt ratios were calculated and data
expressed as (DF/Dt)cerulein - (DF/Dt)untreated (mean 6 SEM, n = 36). *P,0.05 (WT versus corresponding UCP2
-/- mice). The intracellular levels of
trypsinogen (C) and proelastase (D) were assessed by incubating the lysates obtained from unstimulated WT- and UCP2-/- cells of 12 months old mice
with active trypsin as described in the ‘‘Materials and methods’’ section. A value of 100 percent corresponds to the averaged activity of in vitro-
activated trypsin from WT cells. Data are shown as mean 6 SEM (n= 18). *P,0.05 (WT versus corresponding UCP2-/- mice).
doi:10.1371/journal.pone.0094494.g008
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characteristic findings include (1) interstitial edema, (2) cell
swelling, vacuolization and cystic degeneration, (3) cell death by
apoptosis and necrosis and (4) tissue infiltration with inflammatory
cells, and reached a maximum after 8–24 h. Until day 7, an almost
complete restitutio ad integrum was observed (for further details, see
legend to Fig. 3). As an additional finding (which is agreement with
previous studies [37]), large and compact infiltrates of immune
cells, surrounding ducts and vessels, were occasionally detected in
12 months old mice and in exceptional cases also in 3 months old
mice of both strains. The latter type of inflammation, which is
compatible with a chronic autoimmune pancreatitis (AIP) in mice
[38], was independent of cerulein injections (data not shown) and
therefore not considered for scoring. For comparison, Fig. 4 shows
histopathological changes in age-matched UCP2-/- mice. While
the principal findings were identical, a tendency to increased
severity at late time points (24 h and 7 d after start of cerulein
treatment, Fig. 4 D and E) was observed.
For further analysis, histopathological changes were assessed by
semiquantitative scores. At an age of 3 months, WT and UCP2-/-
mice were virtually indistinguishable with respect to their total
histopathological scores at any time point (Fig. 5 A, left panel).
This equal disease severity is also reflected by the sub-scores for the
individual parameters edema (5 B), potentially reversible cell
damage (5 C), cell death (5 D) and presence of inflammatory cells
(5 E), which showed no significant differences between the strains
(with two non-systematic exceptions as indicated in 5 C and 5 E).
In contrast, at an age of 12 months total histopathological scores
differed in that UCP2-/- mice were scored significantly higher at
the two late time points 24 h and 7 d, suggesting a retarded
regeneration process (Fig. 5 A, right panel). In addition to the total
scores, also the sub-scores for individual parameters (Fig. 5 B–E)
point to a slightly increased disease severity in UCP2-/- mice,
although statistically significant differences were rare.
A detailed analysis of inflammatory cell infiltrates (outside of
AIP-like foci) revealed increased numbers of cells expressing
CD11b (monocytes/macrophages, neutrophils, natural killer cells
and granulocytes) and Gr1 (neutrophils), but not of CD3-positive
lymphocytes, in pancreatic tissue of 12 months old mice of both
strains at 24 h after the start of cerulein treatment (Fig. 6A–C ).
Furthermore, a tendency to higher numbers of all three types of
cells in UCP2-/- mice than in WT animals was observed. The
number of apoptotic cells at 0, 8 and 24 h after induction of
pancreatitis did not differ between 12 months old mice of the two
strains (Fig. 6 D).
We also determined levels of active trypsin in pancreatic tissue
of WT and UCP2-/- mice. As expected, in both strains a transient
increase of trypsin activity in the course of experimental
pancreatitis was observed. Although the highest absolute value
was detected in UCP2-/- mice (8 h after the first cerulein injection),
there was not a general tendency to higher levels in the knockout
strain. On the contrary, 3 h after the induction of pancreatitis,
pancreatic trypsin activity was significantly higher in WT mice
(Fig. 7).
Figure 10. MPO activities in pancreatic and lung tissue of cerulein-treated WT and UCP2-/- mice. Tissue samples (A, pancreas; B, lung) of
12 months old mice at the indicated time points after initiation of cerulein treatment (n = 8 per group) were subjected to the quantification of MPO
activity as described in the ‘‘Materials and methods’’ section. Data are expressed as mU/mg wet weight (mean 6 SEM). *P,0.05 (WT versus
corresponding UCP2-/- mice).
doi:10.1371/journal.pone.0094494.g010
Figure 9. ROS levels in pancreatic acini isolated from WT and
UCP2-/- mice. DCFH-DA-labeled pancreatic acini of 12 months old WT
and UCP2-/- mice were treated in vitro with cerulein at the indicated
concentrations for 30 min before fluorescence intensity of 29,79-
dichlorofluorescein was recorded. Data of 6 independent samples per
experimental protocol were used to calculate mean values 6 SEM. *P,
0.05 (WT versus corresponding UCP2-/- mice).
doi:10.1371/journal.pone.0094494.g009
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In vitro Studies with Pancreatic Acini
Using isolated pancreatic acini from 12 months old mice, we
studied intracellular activation of pancreatic proteases in response
to a treatment with cerulein in vitro (Fig. 8). As expected, a rapid
and transient increase of both trypsin (8 A) and elastase (8 B)
activities was observed. Interestingly, activation of both proteases
was significantly stronger in the WT strain than in UCP2-/- mice.
In contrast, the intracellular level of trypsinogen did not differ
between the two strains while proelastase concentration was even
slightly higher in acinar cells of UCP2-/- mice (8 C and D). Thus,
the higher activities of trypsin and elastase in cerulein-treated WT
cells do not result from an increased expression of the proenzymes.
Furthermore, there was no difference in the intraacinar ROS
levels of both strains, independent of the presence or absence of
cerulein (which also displayed no effect at the two concentrations
tested) (Fig. 9). Similar results as presented in Fig. 8 and 9 were
also obtained for 3 months old mice (data not shown). Together,
these data point to effective mechanisms of antioxidative defense
in pancreatic acinar cells and suggest that the increased severity of
cerulein pancreatitis in UCP2-/- mice (Fig. 5) is unrelated to the
investigated acinar cell functions.
MPO Activity in Lung and Pancreatic Tissue of Cerulein-
Treated Mice
Given that (1) cerulein pancreatitis is associated with intrapan-
creatic accumulation of leucocytes and (2) UCP2-/- deficiency has
been linked to dysfunction of monocytes/macrophages [26], we
reasoned that tissue activities of MPO might vary between the two
strains. In pancreatic tissue of 12 months old mice, the highest
absolute value was measured in the knockout strain (24 h after
induction of pancreatitis; Fig. 10), although the differences were
not statistically significant. In lung tissue, MPO activities were
consistently higher in UCP2-/- mice than in control animals (0, 8
and 24 h after the first cerulein injection, respectively), with a
statistically significant difference for the basal activity.
Discussion
The results of this study show that UCP2-/- mice at an advanced
age of 12 months display an increased susceptibility to cerulein-
induced experimental AP. The effect of UCP2 deficiency on the
severity of the disease was altogether moderate, with a more
sustained pancreatic damage (indicated by the histopathological
score; Fig. 5 A) as the main finding. Furthermore, a stronger
increase of a-amylase activity was observed in the knockout strain.
UCP2 functions as a negative regulator of mitochondrial ROS
production and may exert cytoprotective effects [17–21]. Since
pancreatic acinar cells express UCP2 [16], we reasoned that acini
derived from UCP2-deficient mice might show relevant functional
defects. Intraacinar ROS levels, however, were found to be not
increased, suggesting that antioxidant defense of pancreatic acinar
cells is efficient enough to compensate for the loss of the
uncoupling protein. Interestingly, premature activation of the
proteases trypsin and elastase was even attenuated in cells from the
knockout strain. This phenomenon might reflect an adaptive
mechanism of the cells and needs to be studied further at the
molecular level. In agreement with the results of the in vitro
experiments, the in vivo studies showed that cerulein-treated
UCP2-/- mice had at least no higher intrapancreatic levels of
active trypsin than WT animals. Together, both approaches argue
against the possibility that functional defects of pancreatic acinar
cells are responsible for the increased severity of cerulein
pancreatitis in 12 months old UCP2-/- mice.
Previous studies have identified infiltrating leucocytes as the
most important source of excessive pancreatic ROS production in
AP [39,40]. Here, we observed gradually higher levels of
pancreatic MPO activity in the knockout strain. Considering that
macrophages of UCP2-/- mice display a higher oxidative burst
compared to WT macrophages [26,41], it seems likely that the
increased pancreatic damage in the knockout strain is caused, at
least in part, by a ROS-mediated increased activity of infiltrating
leucocytes. Specific mechanisms of UCP2 action in this context
may also include regulatory effects on immune cell migration and
the production of cytokines and nitric oxide, as previously
demonstrated in models of infection, inflammation and autoim-
munity [26]. Of note, increased levels of MPO activity were also
observed in the lungs of cerulein-treated (and untreated) UCP2-/-
mice, suggesting a systemic impact of the knockout in our
experimental model.
In accordance with previous studies [25], we found that the
ratio of GSH/GSSG in serum was lower in UCP2-/- mice of
different age groups than in WT animals (although not to the same
extent as previously reported), suggesting diminished antioxidative
resources throughout the lifespan of the animals. Nevertheless, in
young adult mice (3 months old) no systematic effects of UCP2-
deficiency on the course of experimental AP were observed. Age-
dependent effects of UCP2 have also been detected in other
experimental disease models [25] and may reflect an increasing
importance of the uncoupling protein in ageing individuals in the
context of an increased oxidative stress burden. We therefore
hypothesize that the efficiency of adaptation to a lack of UCP2
expression decreases with the age of the animals.
The precise role of ROS in the pathogenesis of AP is a matter of
ongoing debate. In summary, our results underscore the important
function of ROS-producing inflammatory cells in the progression
of the experimental AP and suggest inflammatory cells as a specific
target for future studies with antioxidants.
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